Paige, a global leader in digital pathology solutions, has received the FDA’s Breakthrough Device Designation for Paige Lymph Node. This AI application is a pioneering tool for detecting breast cancer metastases in lymph nodes….
Continue Reading
Teri Thomas, CEO and Managing Director at Volpara Health
Breast cancer awareness is essential for early detection, which is critical for improving survival rates and reducing the burden of this disease. October is Breast Cancer…
Continue Reading
What You Should Know:
– Cedar Gate Technologies’ advanced AI analytics platform has identified that 55% of commercially insured women are unlikely to get a mammogram. Leveraging this proprietary AI, Cedar Gate evaluated nearly 2.4 million women in its national healthcare benchmark database.
– The model surfaces a probability score for…
Continue Reading
Britannic have streamlined telephony systems, following the merger of Breast Cancer Care with Breast Cancer Now, so to ensure simple telephone operations for both employees and users.Breast Cancer Care were already using the Britannic…
Continue Reading
What You Should Know:
– Densitas®, a provider of artificial intelligence solutions for breast cancer screening, announced a strategic partnership with Intelerad Medical Systems®, a provider of medical imaging software and services to advance AI-driven…
Continue Reading
By Sara Heath
October 17, 2023 – Fewer than half of adults are aware of the common signs of breast cancer, save for having a lump, a clear signal that patient health literacy is faltering, researchers…
Continue Reading
Breast cancer is the most common form of cancer across the world and common risk factors for the disease include age, genetic mutations, personal and family history of breast and ovarian cancer, having dense…
Continue Reading
Lunit and Leeds Teaching Hospitals NHS Trust are launching the world’s first prospective study of AI-powered breast screening in symptomatic clinics, using Lunit INSIGHT MMG. This innovative initiative aims to improve breast cancer detection,…
Continue Reading
Lunit’s AI-powered solution, SCOPE IO, is transforming breast cancer care by improving the assessment of tumor-infiltrating lymphocytes (TILs). In a groundbreaking study, SCOPE IO demonstrated remarkable concordance with pathologists’ evaluations, reducing discordant cases significantly….
Continue Reading
By Shania Kennedy
September 19, 2023 – The diagnostic performance of a commercially available artificial intelligence (AI) algorithm was comparable with that of human readers of mammograms, according to a study published recently in Radiology.
Screening mammograms…
